|
Name |
N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]benzamide
|
Molecular Formula | C16H17NO2 | |
IUPAC Name* |
N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]benzamide
|
|
SMILES |
C1=CC=C(C=C1)C[C@@H](CO)NC(=O)C2=CC=CC=C2
|
|
InChI |
InChI=1S/C16H17NO2/c18-12-15(11-13-7-3-1-4-8-13)17-16(19)14-9-5-2-6-10-14/h1-10,15,18H,11-12H2,(H,17,19)/t15-/m0/s1
|
|
InChIKey |
RFYNAVYPYXLVOM-HNNXBMFYSA-N
|
|
Synonyms |
N-benzoylphenylalaninol; (S)-N-(1-Hydroxy-3-phenylpropan-2-yl)benzamide; 4503-96-2; N-Benzoyl-L-phenyalaninol; Oprea1_816797; N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]benzamide; CHEMBL469704; SCHEMBL3682311; CHEBI:145107; ZINC387871; (S)-2-Benzoylamino-3-phenyl-1-propanol; (S)-N-(1-Benzyl-2-hydroxyethyl)benzamide; V10326
|
|
CAS | NA | |
PubChem CID | 852848 | |
ChEMBL ID | CHEMBL469704 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 255.31 | ALogp: | 2.5 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 49.3 | Aromatic Rings: | 2 |
Heavy Atoms: | 19 | QED Weighted: | 0.863 |
Caco-2 Permeability: | -5.188 | MDCK Permeability: | 0.00012844 |
Pgp-inhibitor: | 0.025 | Pgp-substrate: | 0.466 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.985 |
30% Bioavailability (F30%): | 0.978 |
Blood-Brain-Barrier Penetration (BBB): | 0.681 | Plasma Protein Binding (PPB): | 90.99% |
Volume Distribution (VD): | 0.848 | Fu: | 7.83% |
CYP1A2-inhibitor: | 0.818 | CYP1A2-substrate: | 0.076 |
CYP2C19-inhibitor: | 0.481 | CYP2C19-substrate: | 0.087 |
CYP2C9-inhibitor: | 0.469 | CYP2C9-substrate: | 0.138 |
CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.355 |
CYP3A4-inhibitor: | 0.08 | CYP3A4-substrate: | 0.23 |
Clearance (CL): | 7.907 | Half-life (T1/2): | 0.825 |
hERG Blockers: | 0.152 | Human Hepatotoxicity (H-HT): | 0.544 |
Drug-inuced Liver Injury (DILI): | 0.803 | AMES Toxicity: | 0.029 |
Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.039 |
Skin Sensitization: | 0.494 | Carcinogencity: | 0.196 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.325 |
Respiratory Toxicity: | 0.027 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000077 | 0.594 | D0G1VX | 0.594 | ||||
ENC000295 | 0.554 | D0T5UL | 0.507 | ||||
ENC000093 | 0.548 | D04DXN | 0.466 | ||||
ENC001737 | 0.480 | D0J5RN | 0.434 | ||||
ENC001523 | 0.479 | D07HQC | 0.434 | ||||
ENC000302 | 0.446 | D0D4PB | 0.420 | ||||
ENC003032 | 0.430 | D03HCZ | 0.416 | ||||
ENC005603 | 0.427 | D0X2DK | 0.415 | ||||
ENC003342 | 0.414 | D06FZX | 0.402 | ||||
ENC005604 | 0.411 | D0M9DC | 0.400 |